RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $304,000 | -47.3% | 55,123 | -7.4% | 0.00% | -100.0% |
| Q4 2021 | $577,000 | -44.1% | 59,560 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $1,033,000 | -31.9% | 57,795 | -7.0% | 0.00% | -50.0% |
| Q2 2021 | $1,517,000 | +6.0% | 62,150 | +15.1% | 0.00% | 0.0% |
| Q1 2021 | $1,431,000 | +249.0% | 53,993 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $410,000 | +51.3% | 53,993 | 0.0% | 0.00% | – |
| Q3 2020 | $271,000 | -16.1% | 53,993 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $323,000 | +34.6% | 53,993 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $240,000 | -52.7% | 53,993 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $507,000 | +20.1% | 53,371 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $422,000 | -50.1% | 53,799 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $846,000 | -11.5% | 53,799 | +1.9% | 0.00% | 0.0% |
| Q1 2019 | $956,000 | +205.4% | 52,807 | +170.9% | 0.00% | +100.0% |
| Q4 2018 | $313,000 | -29.0% | 19,490 | +6.0% | 0.00% | 0.0% |
| Q3 2018 | $441,000 | – | 18,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |